{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:53:20Z","timestamp":1771847600415,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.parkreldis.2020.08.035","type":"journal-article","created":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T18:53:15Z","timestamp":1598813595000},"page":"10-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Self-reported benefit and weakness after botulinum toxin in dystonia"],"prefix":"10.1016","volume":"80","author":[{"given":"Panagiotis","family":"Kassavetis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Codrin","family":"Lungu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine","family":"Alter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara I.","family":"Karp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2020.08.035_bib1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/mds.23504","article-title":"Long-term follow-up of botulinum toxin therapy for focal hand dystonia: outcome at 10 years or more","volume":"26","author":"Lungu","year":"2011","journal-title":"Mov. Disord."},{"issue":"Suppl 8","key":"10.1016\/j.parkreldis.2020.08.035_bib2","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1002\/mds.20025","article-title":"Botulinum toxin treatment of occupational and focal hand dystonia","volume":"19","author":"Karp","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.08.035_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.toxicon.2015.07.013","article-title":"Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them","volume":"107","author":"Hallett","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.parkreldis.2020.08.035_bib4","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.3390\/toxins4111404","article-title":"Botulinum toxin physiology in focal hand and cranial dystonia","volume":"4","author":"Karp","year":"2012","journal-title":"Toxins"},{"key":"10.1016\/j.parkreldis.2020.08.035_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jmor.1051800307","article-title":"A comparison of spindle concentrations in large and small muscles acting in parallel combinations","volume":"180","author":"Peck","year":"1984","journal-title":"J. Morphol."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020307094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020307094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:19:11Z","timestamp":1761178751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802020307094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":5,"alternative-id":["S1353802020307094"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.08.035","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-reported benefit and weakness after botulinum toxin in dystonia","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.08.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}